Takara Bio Inc., a biotechnology company in Otsu, Japan, has developed a system which allows for mass production of a wide variety of DNA (deoxyribonucleic acid) fragments needed to make DNA ...
Phase I and Pharmacologic Study of Oral ZD9331, A Novel Nonpolyglutamated Thymidylate Synthase Inhibitor, in Adult Patients With Solid Tumors ABSTRACT: Aberrant gene expression is critical for tumor ...
Reported Data Supports the Potential Extension of HD-MAP Vaccine Delivery to Oncology Indications Recently published data generated by researchers at The University of Queensland and Vaxxas shows ...
URBANA, ILLINOIS Millions of people take herbal remedies for conditions ranging from mild problems such as the common cold to severe disorders, such as Alzheimer's disease. But even when these types ...
Some credit for this revolution must go to the tools' manufacturers, who seem to have a knack for giving their customers exactly what they want, whether it be chip sets representing every gene in the ...
The global DNA methylation market size was valued at US$ 1.9 Bn in 2025 and is projected to reach US$ 7.7 Bn by 2036, growing ...
Illumina has recently advanced its plan to divest its cancer-diagnostics unit, a move intended to ease regulatory pressure and sharpen its focus on core DNA sequencing and microarray technologies.
When you purchase through links on our site, we may earn an affiliate commission. Here’s how it works. DNA tests can tell people where in the world their ancestors came from, and if they're at risk of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback